We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT05173987
Brief Title: Study of Pembrolizumab (MK-3475) Versus Chemotherapy in Mismatch Repair Deficient (dMMR) Advanced or Recurrent Endometrial Carcinoma (MK-3475-C93/KEYNOTE-C93/GOG-3064/ENGOT-en15)

First Submitted : December 20, 2021
First Submitted that Met QC Criteria : December 20, 2021
First Posted : December 30, 2021

Last Update Submitted that Met QC Criteria : September 26, 2022
Last Update Posted : September 27, 2022